Gene that regulates tumours in neuroblastoma identifiedJune 2nd, 2009 - 3:10 pm ICT by ANI
Washington, June 2 (ANI): Scientists from Virginia Commonwealth University have identified a gene that may play a key role in regulating tumour progression in neuroblastoma, a form of cancer usually found in young children.
Lead researcher Dr Paul B. Fisher, M.Ph., from Thelma Newmeyer Corman Endowed Chair in Cancer Research has shown astrocyte elevated gene-1, AEG-1, a cancer promoting gene, is frequently activated in neuroblastoma.
MYCN is a known genetic determinant of neuroblastoma and elevated levels have been observed in one third of neuroblastoma patients.
The researchers found a potential correlation between AEG-1 and MYCN in neuroblastoma.
“We believe that activation of AEG-1 in addition to MYCN is critical to the development and progression of neuroblastoma,” said Fisher.
“This works shows that AEG-1 plays a crucial role in the development and progression of neuroblastoma through activating important signaling pathway and induction of MYCN.
“In addition, we have shown that AEG-1 could be a potential prognostic marker for neuroblastoma and a potential target for novel therapeutic strategies for neuroblastoma patients,” he added.
The team found that the elevated expression of AEG-1 makes cancer cells highly aggressive and resistant to factors that may influence cell suicide, and that loss of AEG-1 reduces the tumour-causing properties of highly aggressive neuroblastoma cells.
The study is published in the journal Oncogene. (ANI)
Tags: aeg, cancer cells, cancer research, cell suicide, correlation, determinant, dr paul, induction, journal oncogene, key role, neuroblastoma cells, neuroblastoma patients, newmeyer, prognostic marker, signaling pathway, target, thelma, therapeutic strategies, tumours, virginia commonwealth university